Joel Greenblatt - Gotham Asset Management
Holding/activity history for Apellis Pharmaceuticals, Inc. (APLS)
← All APLS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 78,750 | <0.01 | Reduce 53.25% | <0.01 | $40.23 | $3,168,113 | SEC |
| 2025 Q4 | 168,455 | 0.02 | Add 32.48% | <0.01 | $25.12 | $4,231,590 | SEC |
| 2025 Q3 | 127,158 | 0.01 | Add 6.65% | <0.01 | $22.63 | $2,877,586 | SEC |
| 2025 Q2 | 119,229 | 0.01 | Add 247.76% | <0.01 | $17.31 | $2,063,854 | SEC |
| 2025 Q1 | 34,285 | <0.01 | Add 41.10% | <0.01 | $21.87 | $749,813 | SEC |
| 2024 Q4 | 24,299 | <0.01 | Buy | <0.01 | $31.91 | $775,381 | SEC |
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2024 Q1 | 3,513 | <0.01 | $58.78 | $206,494 | SEC | ||
| 2023 Q4 | 3,513 | <0.01 | Buy | <0.01 | $59.86 | $210,288 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q2 | 2,720 | <0.01 | Reduce 29.39% | <0.01 | $91.10 | $247,792 | SEC |
| 2023 Q1 | 3,852 | <0.01 | Buy | <0.01 | $65.96 | $254,078 | SEC |
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2022 Q3 | 4,458 | <0.01 | Buy | <0.01 | $68.19 | $304,000 | SEC |